Acumen Pharmaceuticals Files 8-K with Material Agreement
Ticker: ABOS · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1576885
| Field | Detail |
|---|---|
| Company | Acumen Pharmaceuticals, INC. (ABOS) |
| Form Type | 8-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, pharmaceuticals
Related Tickers: ACUM
TL;DR
ACUM filed an 8-K for a material agreement, check it out.
AI Summary
On July 15, 2025, Acumen Pharmaceuticals, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes information regarding Regulation FD disclosure and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Newton, Massachusetts.
Why It Matters
This 8-K filing indicates a significant new agreement for Acumen Pharmaceuticals, which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood by the market.
Key Numbers
- 001-40551 — SEC File Number (Identifies the company's filings with the SEC.)
- 36-4108129 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Acumen Pharmaceuticals, Inc. (company) — Registrant
- July 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Newton, Massachusetts (location) — Address of Principal Executive Offices
- 001-40551 (identifier) — SEC File Number
FAQ
What is the nature of the material definitive agreement filed by Acumen Pharmaceuticals?
The filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary information.
When was the earliest event reported in this 8-K filing?
The earliest event reported is July 15, 2025.
Where are Acumen Pharmaceuticals' principal executive offices located?
The principal executive offices are located at 1210-1220 Washington Street, Suite 210, Newton, Massachusetts 02465.
What is Acumen Pharmaceuticals' SIC code?
Acumen Pharmaceuticals' Standard Industrial Classification (SIC) code is 2836, for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
What is the company's fiscal year end?
The company's fiscal year ends on December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding Acumen Pharmaceuticals, Inc. (ABOS).